Hera News & Events

­

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than [...]

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

Transgenic Rats as Research Models Boast Significant Benefits….

Transgenic Rats as Research Models Boast Significant Benefits over Mouse [...]

Humanized Mouse Xenograft Models: The Best of Both Worlds

Xenograft rodent models and cultured cells have long been used [...]

Xenograft Rat Models Give Hope to New Therapeutic Treatments for Leukemia

Mutations in DNA methyltransferase 3A (DNMT3A) are common in acute [...]

Hera BioLabs in Genetic Engineering News

Hera BioLabs and our VP of Research and Development Tseten [...]

Advancements in Stem Cell-Based Therapies for Malignant Brain Tumors

Despite many great developments in the overall treatment of cancers, [...]

Hera BioLabs Receives PHS Approved Animal Welfare Assurance

Hera BioLabs, Inc. (Lexington KY) announced today that it has [...]

Humanized Rodent Models: A Critical Research Tool

Chimeric humanized liver rodent models are being used by those [...]

Lexington based toxicology lab, Hera BioLabs, partners with the NIH to use firefly proteins for drug discovery research

Hera BioLabs, a Lexington based contract research organization (CRO), announced [...]